Release Date: 25/02/19 18:13 Summary: Dividend/Distribution - ATL Price Sensitive: No Download Document 32.48KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%